Online Inquiry
Cat.#: ACPP-1206
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1297 | p75 NGF Receptor Blocking Peptide (AC1297) | 250 µg | inquiry |
| ACPP-1175 | Recombinant Mouse Syndecan-1 Protein (Fc Tag) (AC1175) | 50 µg | inquiry |
| ACPP-1765 | Human PQBP1 Protein (AC1765) | 5 µg | inquiry |
| ACPP-1125 | Recombinant Human ERAB Protein (S Tag) (AC1125) | 50 µg | inquiry |
| ACPP-1586 | Human SERPINI1 Protein (AC1586) | 5 µg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1804 | Human STMN2 Protein (AC1804) | 2 µg | inquiry |
| ACPP-1830 | Human SDC1 Protein (AC1830) | 5 µg | inquiry |
| ACPP-1016 | Synthetic Nanodisc Human GnRHR Protein (AC1016) | 10 µg | inquiry |
| ACPP-1519 | Human MANF Protein (AC1519) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.